You are here

China Resilience Initiative

Primary tabs

Group description: 
This Working Group is focused on developing a China Resilience Initiative to ensure resilience and sustainability for citizens of China.
Group roles and permissions: 
Use default roles and permissions
Group visibility: 
Public - accessible to all site users

Members

admin Albert Gomez ChrisAllen efrost Kathy Gilbeaux Maeryn Obley
QuentinEichbaum

Email address for group

Merck's COVID-19 pill to be produced by drugmakers in 11 additional countries

 

Merck's COVID-19 pill to be produced by more than two dozen drugmakers

Medicines Patent Pool, an organization supported by the U.N., announced on Thursday that over two dozen generic drug makers will soon begin producing Merck's COVID-19 pill to make the treatment more accessible in developing countries.

The organization said that 27 generic drug makers would produce the pill for 105 developing countries. Specifically, agreements the companies signed allow them to make both molnupiravir's raw ingredients as well as the final product.

Molnupiravir is the COVID-19 treatment developed by Merck and Ridgeback Therapeutics. For patients with early signs of COVID-19, the pill is believed to cut the hospitalization rates in half.

Problem, Solution, SitRep, or ?: 

Overview: International developments-_Australia, Asia, Europe

-- Australia suffered its deadliest day of the pandemic on Tuesday as a fast-moving Omicron outbreak continued to push up hospitalisation rates to record levels, even as daily infections eased slightly.

Problem, Solution, SitRep, or ?: 

Overview: Asia, the UK, Canada COvid-related developments

-- South Korea said on Friday it would extend stricter social distancing rules for two weeks amid a persistent surge in serious coronavirus infections and concerns over the spread of the highly contagious Omicron variant.

Problem, Solution, SitRep, or ?: 

China to start vaccinating children to age 3 as cases spread

TAIPEI, Taiwan (AP) — Children as young as 3 will start receiving COVID-19 vaccines in China, where 76% of the population has been fully vaccinated and authorities are maintaining a zero-tolerance policy toward outbreaks.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

China’s COVID vaccines have been used wiidely but immunity is now waning

China’s CoronaVac and Sinopharm vaccines account for almost half of the 7.3 billion COVID-19 vaccine doses delivered globally, and have been enormously important in fighting the pandemic, particularly in less wealthy nations.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO Seeks to Revive Stalled Inquiry into COVID-19 Origins

The World Health Organization is reviving its stalled investigation into the origins of COVID-19 with a new team of about 20 scientists. The team—including specialists in laboratory safety and biosecurity and geneticists and animal-disease experts versed in how viruses spill over from nature—is being assembled with a mandate to find new evidence in China and elsewhere. The possibilities that the new team is charged with examining include whether the COVID-19 virus could have emerged from a lab, according to WHO officials.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO begins shipping Chinese vaccines despite some misgivings

BRUSSELS/JOHANNESBURG/JAKARTA (Reuters) -The World Health Organization’s pandemic programme plans to ship 100 million doses of the Sinovac and Sinopharm COVID-19 shots by the end of next month, mostly to Africa and Asia, in its first delivery of Chinese vaccines, a WHO document shows.

Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.734 seconds.